Emerging treatment for epidermolysis bullosa acquisita

Journal of the American Academy of Dermatology
Leela Engineer, A R Ahmed

Abstract

Epidermolysis bullosa acquisita (EBA) is a rare, chronic, subepidermal, mucocutaneous blistering disease characterized by skin fragility and spontaneous as well as trauma-induced blisters that heal with scar formation and milia. Treatment is often frustrating because conventional therapy with corticosteroids and immunosuppressive agents frequently does not result in significant clinical improvement. We review the conventional treatment of EBA and critically analyze the literature on various adjuvants and therapeutic modalities that have recently been used. These include cyclosporine, colchicine, plasmapheresis, extracorporeal photochemotherapy, and intravenous gammaglobulins. Although the data are preliminary, they suggest that intravenous immunoglobulins may be a promising treatment modality for resistant, nonresponsive, or refractory EBA. The use of intravenous immunoglobulins results in significant improvement of skin and mucosal lesions, and it is quite safe, with minimal side effects.

Citations

Dec 16, 2003·Skinmed·Nitsan Maharshak, Sarah Brenner
Mar 25, 2008·Therapeutics and Clinical Risk Management·Diya F Mutasim
Jan 24, 2004·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Dordije Karadaglić, Milica Popović
Oct 17, 2015·Expert Review of Clinical Immunology·Ralf Ludwig
Jul 23, 2004·Expert Opinion on Investigational Drugs·A Razzaque Ahmed
Oct 1, 2011·Autoimmunity·Mei ChenDavid T Woodley
May 1, 2004·International Journal of Dermatology·Ozgür BakarTulin Ergun
Sep 27, 2003·Dermatologic Therapy·S W YehA Razzaque Ahmed
Jun 29, 2007·The British Journal of Dermatology·E SadlerJ W Bauer
Sep 6, 2007·The Journal of Small Animal Practice·P B HillT Olivry
May 15, 2007·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Norio HanafusaToshiro Fujita
Mar 9, 2007·International Journal of Dermatology·Zrinjka PastarTakashi Hashimoto
Nov 1, 2007·Dermatologic Therapy·V Madan, C E M Griffiths
Jan 25, 2011·Expert Opinion on Pharmacotherapy·Hakan M Gürcan, A Razzaque Ahmed
Mar 1, 2006·International Immunopharmacology·A Razzaque Ahmed
Oct 21, 2014·The Journal of Investigative Dermatology·Hiroaki IwataRalf J Ludwig
Jan 20, 2007·Journal of Cutaneous Medicine and Surgery·P Régine MydlarskiNeil H Shear
Sep 8, 2004·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·S RitzmannM Megahed
Jun 16, 2006·The British Journal of Dermatology·C E M GriffithsK Thestrup-Pedersen
Mar 6, 2009·International Journal of Dermatology·Julia S LehmanLawrence E Gibson
Sep 18, 2009·Annals of the New York Academy of Sciences·Anupama BhatM Eric Gershwin
May 29, 2010·The Journal of Dermatology·Norito IshiiTakashi Hashimoto
Jun 27, 2009·Clinical Reviews in Allergy & Immunology·Norito IshiiRalf J Ludwig
Oct 15, 2010·Anais Brasileiros De Dermatologia·Carolina Balbi MosqueiraAlda Maria Penna Galvão
Sep 8, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·N Wallet-FaberN Dupin
May 24, 2005·The Journal of Dermatology·Komal Pahuja AroraSambit Nath Bhattacharya
Oct 28, 2019·The Journal of Dermatology·Hideyuki UjiieUNKNOWN Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita)
Jul 29, 2021·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Parisa HeydariShaghayegh Haghjooy Javanmard
Nov 26, 2010·Journal of the American Academy of Dermatology·Karrie T AmorAlan Menter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the European Academy of Dermatology and Venereology : JEADV
K GourgiotouA D Katsambas
Journal of the American Academy of Dermatology
B B CunninghamD T Woodley
Archives of Dermatological Research
M Megahed, K Scharffetter-Kochanek
Journal of the American Academy of Dermatology
Leela EngineerA R Ahmed
© 2021 Meta ULC. All rights reserved